ArticlebioRxiv : the preprint server for biology2025
SpaGene: A Deep Adversarial Framework for Spatial Gene Imputation.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Integrating transcriptome-wide single-cell gene expression data with spatial context significantly enhances our understanding of tissue biology, cellular interactions, and disease progression. Although single-cell RNA sequencing (scRNA-seq) provides high-resolution gene expression data, it lacks crucial spatial context, whereas spatial transcriptomics techniques offer spatial resolution but are limited in the transcriptomic coverage. To address these limitations, integrating scRNA-seq and spatial transcriptomics data is essential. We introduce SpaGene, a novel deep learning framework designed to integrate scRNA-seq data and spatial transcriptomics data. SpaGene consists of two encoder-decoder pairs combined with two translators and two discriminators to effectively impute missing gene expressions within spatial transcriptomics datasets. We benchmarked SpaGene against existing state-of-the-art methods across diverse datasets. Across the datasets, SpaGene achieved an average 33% higher Pearson correlation coefficient (PCC), 21% higher Structural similarity index (SSIM), and 6.6% lower Root mean squared error (RMSE) compared to the existing approaches, highlighting its capability to reliably impute missing genes and provide comprehensive transcriptomics profiles. Application of our model to lung tumor tissue revealed immune cell enrichment at tumor boundaries, restricted myeloid cell trafficking in adjacent normal regions, and microenvironmental-driven pathways linked to immune neighborhoods. These results provide novel insight into immune exclusion and tumor-immune interactions that drive tumor progression, highlighting potential avenues for therapeutic development. Thus, SpaGene extends the power of spatial transcriptomics by delivering spatially resolved, enhanced transcriptome data that enable deeper biological understanding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.